Higher serum aldosterone levels among patients with chronic kidney disease (CKD) are independently associated with an increased risk for CKD progression and end-stage kidney disease (ESKD) regardless ...
The 2017 KDIGO guideline for CKD-MBD may be too conservative, according to investigators. Observational study data suggest that it may be possible to prevent development of secondary ...
A retrospective study found roxadustat to be more effective in improving hemoglobin levels in patients who had with chronic kidney disease (CKD) compared with recombinant human erythropoietin.
Credit: Getty Images In advanced CKD stages, patients are not only at risk of low bone mass but also of poor bone quality. Abnormalities in phosphorus, iPTH, and FGF-23 levels can increase the risk ...
Longitudinal monitoring of the CKD-REIN cohort reveals that twothirds of patients with renal insufficiency have a stable haemoglobin trajectory and a low associated risk of cardiorenal complications ...
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan–Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors Wee1 tyrosine kinase phosphorylates and inactivates ...
A new study published in The Journal of Rheumatology showed that despite using lower dosages, febuxostat more successfully ...
The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State We retrospectively analyzed a multi-institutional cohort of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback